Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$87.28 USD
+1.16 (1.35%)
Updated May 10, 2024 04:00 PM ET
After-Market: $87.19 -0.09 (-0.10%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $1.11 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.20 per share, beating the Zacks Consensus Estimate of $1.13 per share. This reflects a positive earnings surprise of 6.19%. Look out for LGND's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of $1.11 per share, reflecting a year-over-year decrease of 21.83%.
Earnings History
Price & Consensus
Zacks News for LGND
Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services